Sign in
4

Changes in Ownership

PHIBRO ANIMAL HEALTH CORP Filed Acc 0001144204-17-044479

Exec. VP, Corporate Strategy sold 4,976 shares at an average $40.01 ($199,098)

  • Exec. VP, Corporate Strategy acquired 4,976 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bendheim Daniel M Exec. VP, Corporate Strategy 2017-08-17 Option exercise +4,176 $11.83 $49,402 4,176 D: show line 1 in the form
Bendheim Daniel M Exec. VP, Corporate Strategy 2017-08-17 Sale −4,176 $40.01 $167,082 0 D: show line 2 in the form
Bendheim Daniel M Exec. VP, Corporate Strategy 2017-08-21 Option exercise +800 $11.83 $9,464 800 D: show line 3 in the form
Bendheim Daniel M Exec. VP, Corporate Strategy 2017-08-21 Sale −800 $40.02 $32,016 0 D: show line 4 in the form
Open-market sales · 4,976 sh · avg $40.01 · $199,098

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bendheim Daniel M Exec. VP, Corporate Strategy 2017-08-17 Option exercise · Option to purchase Common Stock −4,176 27,923 D: show line 5 in the form
Bendheim Daniel M Exec. VP, Corporate Strategy 2017-08-21 Option exercise · Option to purchase Common Stock −800 27,123 D: show line 6 in the form
Loading xslF345X03/v473786_form4.xml…